Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by juicyjmillson Nov 23, 2020 2:20pm
949 Views
Post# 31953926

Do you live under a rock??

Do you live under a rock??I have been telling you that the markets are not interested in biotech right now. Have you not caught on the digital revolution?? If you havn't gotten out of ATE and into digital assets by now... you are not responsible enough to be in the markets. PERIOD.

Who ever holds digital assets will be the only winners this decade. You already would have 5x your money since when I initially told you about this.

Please for the sake of my beloved antibe investors, MARKETS CHANGE, THIS INVESTMENT WILL SUCK YOUR MONEY DRY.

Nobody is going to buy ATE for years to come, and big corporations will laugh at you for thinking thats there is a demand for that in the market right now. All the big corporations are buying digital assets so that they dont get dissolved in the future markets. 

Buy now or buy my 100x digital assets with the pennies you have left from this stock.

ATE science is amazing.

Markets dont give af.
<< Previous
Bullboard Posts
Next >>